Alan Lotvin

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Avon, CT
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Todd Girolamo, attorney in fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Alan Lotvin

Form 4 holding EVP&President-PharmacyServices

CVS HEALTH Corp

Security class
Common Stock
Shares / value
109,183
Estimated value
$8,110,141
Report date
04 Aug 2022
Price
$74.28
Ownership
Direct
Form 4 holding EVP&President-PharmacyServices

CVS HEALTH Corp

Security class
Common Stock (restricted)
Shares / value
5,827
Estimated value
$399,033
Report date
03 Aug 2022
Price
$68.48
Ownership
Direct
Form 4 holding EVP&President-PharmacyServices

CVS HEALTH Corp

Security class
Common Stock
Shares / value
492
Estimated value
$36,546
Report date
03 Aug 2022
Price
$74.28
Ownership
By Children's Trusts
Form 4 holding Director

PROKIDNEY CORP.

Security class
Director stock option (right to buy)
Shares / value
135,000
Estimated value
Report date
28 May 2026
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding EVP&President-PharmacyServices

CVS HEALTH Corp

Security class
Stock Unit
Shares / value
30,177
Estimated value
Report date
03 Aug 2022
Price
Ownership
Direct
Form 4 holding EVP&President-PharmacyServices

CVS HEALTH Corp

Security class
Phantom Stock Credits
Shares / value
554
Estimated value
Report date
03 Aug 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
554
Form 4 holding EVP&President-PharmacyServices

CVS HEALTH Corp

Security class
Stock Option
Shares / value
0
Estimated value
Report date
04 Aug 2022
Price
$67.95
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Alan Lotvin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .